Novavax | NVAX - Чистый доход





Чистый доход Изменить Дата
Adma Biologics USD 49.38M 12.95M 2025-12
Agenus USD -10.63M 74.49M 2025-12
AstraZeneca USD 3.08B 754M 2026-03
BioCryst Pharmaceuticals USD 245.84M 232.95M 2025-12
Cassava Sciences USD -12.54M 1.73M 2025-12
Geron USD -3.64M 27.5M 2026-03
GlaxoSmithKline GBP 1.74B 1.1B 2026-03
MannKind USD -15.95M 23.93M 2025-12
Merck USD -4.24B 7.2B 2026-03
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Moderna USD -1.34B 517M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD 2.69B 4.34B 2026-03
Sanofi EUR 1.61B 2.42B 2026-03
Sarepta Therapeutics USD 330.96M 743.18M 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03